Trial intelligence / Profile preview

Remimazolam vs Propofol for General Anesthesia in Cardiac Surgery

NCT02523859Phase 3Terminated

Sponsor
PAION AG
Start
Jul 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of remimazolam in general anesthesia, sponsored by PAION AG. Started Jul 2015; status: terminated.

02

Drugs

remimazolam
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT02523859.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02523859.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call